Medical marijuana maker Vireo Health sets its sights on FDA
As an emergency room doctor, Kyle Kingsley felt frustration at seeing the drug-addicted patients return to his ER over and over, trying to find a doctor who would prescribe them more opioid painkillers.
Those pain pills cause twice as many deaths in Minnesota as street heroin, even though both are made from same plant, the poppy. Now Kingsley is hoping to use a different plant — cannabis — to divert pain patients from opioids to marijuana drugs. But the ambitious plan will require approval from one of the toughest bureaucracies on the planet: The U.S. Food and Drug Administration.